Pharmaceuticals, Inc. (NASDAQ: ARIA) today reported financial
results for the second quarter of 2014, including revenue from sales of Iclusig ®
(ponatinib). The Company also provided an update on corporate
Time Warner remains 10% lower after profit tops views
Shares of Time Warner Inc.(TWX)remained 10% lower after the media company reported profit that topped Wall Street expectations Wednesday Morning.
Networks (Nasdaq: SONS), a global
leader in securing real-time communications , today announced its
participation in the following investor conferences:
On Tuesday, August 12, at 11:30 a.m. Eastern Time, Ray Dolan, President
and Chief Executive Officer, will present at the Pacific Crest Global
Technology Leadership Forum in Vail, Colo.
Significant top-line momentum in both Canada and the U.S. and strong
operating performance contributes to 13.6% EPS increase
(Unaudited. All amounts in Canadian dollars and presented in accordance
with U.S. GAAP.)
Financial & Sales Highlights
- Record fourth quarter sales, operating cash flow and full year sales - Fourth quarter earnings per diluted share $1.98, or $2.06 adjusted for restructuring expenses
- Additional, one-time, fourth quarter restructuring related costs estimated at $0.10 per diluted share - Company anticipates record year in fiscal 2015 with earnings guidance in the range of $7.00 to $7.80 per diluted share, or $7.25 to $8.05 adjusted for restructuring CLEVELAND , Aug.
PAR Technology Corporation (NYSE:PAR) today announced that its
subsidiary, Rome Research Corporation (RRC), was awarded a five-year
(one base plus four options) firm-fixed-price contract with a potential
total value of $23.5 million.
Molson Coors Brewing Company (NYSE: TAP; TSX: TPX) today reported a 7.9
percent increase in underlying after-tax income for the second quarter
2014, driven by improved performance from MillerCoors and Europe, along
with lower interest expense versus a year ago.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.